Özlem KURT AZAP, Hande ARSLAN, Sedef Ö. KARAMAN, Turhan TOGAN

Risk Factors for Fecal Carriage of Extended-Spectrum Beta-Lactamase Producing Escherichia coli and Klebsiella spp. in the Community

Aim: Community-acquired infections caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria are an emerging problem. Digestive tract colonization is a prerequisite for infections by ESBL-producing microorganisms. The aim of this study was to determine the prevalence of and risk factors for fecal carriage of ESBL-producing Escherichia coli (E. coli) or Klebsiella spp. in the community. Materials and Methods: A total of 928 stool samples admitted to the laboratory during a four-month period were included in the study. Samples were diluted in saline and cultured in two EMB agar plates supplemented with either 1 µg/ml cefotaxime or 1 µg/ml ceftazidime. All isolates that grew were identified to the species level. E. coli and Klebsiella spp. strains were tested for ESBL production with ceftazidime and ceftazidime-clavulanate discs according to the Clinical and Laboratory Standards Institute (CLSI) Guideline. Results: Of the 928 stool samples included, 133 (14%) were isolated from inpatients and 795 (86%) from outpatients. Sixty-three (47.3%) of 133 hospitalized and 121 (15.2%) of 795 outpatients harbored ESBL-producing E. coli and Klebsiella spp. (P = 0.000). Chronic hepatic failure (OR: 8.7, CI: 1.65-46.12; P = 0.011) and recent antibiotic use (OR: 4.4, CI: 1.76-11.16; P = 0.002) were found to be associated with ESBL positivity for the hospitalized patients. Recent antibiotic use (OR: 2.8, CI: 1.61-5.12; P = 0.000) was found to be the only independent variable associated with ESBL positivity for the outpatients. Conclusions: The high prevalence (15.2%) of fecal carriage of ESBL-producing bacteria in the community warrants further study in this field including the consequences of this colonization in the hospital setting.

Anahtar Kelimeler:

ESBL positivity, fecal carriage, risk factors, E. coli, Klebsiella spp.

Risk Factors for Fecal Carriage of Extended-Spectrum Beta-Lactamase Producing Escherichia coli and Klebsiella spp. in the Community

Keywords:

ESBL positivity, fecal carriage, risk factors, E. coli, Klebsiella spp.,

PDF

___

Lucet JC, Chevret S, Decre DI. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22: 430-436.
Moustaoui N, Bensghir R, Mjahed K, Hakim K, Aimhand R, Boudouma M et al. Digestive tract colonization with extended- spectrum beta-lactamase producing Enterobacteriaceae in a surgi- cal intensive care unit in Casablanca. J Hosp Infect 2000; 46: 238-240.
Valverde A, Teresa MC, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769-4775.
Millar MR, Walsh TR, Linton JC, Zhang S, Leeming JP, Bennett PM and the ALSPAC Study Team. J Antimicrob Chemother 2001; 47: 605-610.
Clinical and Laboratory Standards Institute (CLSI), formerly NCCLS. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI/NCCLS docu- ment M100-S15. Wayne, PA: CLSI, 2005.
Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Per- sistent colonization and the spread of antibiotic resistance in noso- comial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004; 101: 3709-3714.
Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis 2001; 33(Suppl 3): S161-169.
Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, Voorhis JV, Nathan C et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection-con- trol variable. Arch Intern Med 1998; 158: 1127-1132.
Brinas L, Zarazaga M, Saenz Y, Ruiz-Larrea F, Torres C. ß-Lacta- mases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 2002; 46: 3156-3163.
Österblad M, Hakanen A, Manninen R, Leistevuo T, Peltonenn R, Meurman O et al. A between-species comparison of antimicrobial resistance in Enterobacteria in fecal flora. Antimicrob Agents Chemother 2000; 44: 1479-1484.
Mirelis B, Navarro F, Miro E, Mesa RJ, Coll P, Prats G. Commu- nity transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 2003; 9: 1024-1025.
Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-523.
Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-produc- ing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089-1094.
Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39: 75-80.
Gniadkowski M. Evolution and epidemiology of extended-spec- trum beta-lactamases (ESBLs) and ESBL-producing microorgan- isms. Clin Microbiol Infect Dis 2001; 7: 597-608.
Arslan H, Azap ÖK, Ergönül Ö, Timurkaynak F, on behalf of the Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005; 56: 914-918.